文献速递脊柱关节炎

强直性脊柱炎髋关节受累高发且TNF-α阻断治疗可减少炎症超声病变

High prevalence of hip involvement and decrease in inflammatory ultrasound lesions during tumour necrosis factor-α blocking therapy in ankylosing spondylitis.
PubMed 文献 · Rheumatology (Oxford) · 2019-01-01

该研究纳入111例开始TNF-α阻断治疗的活动性强直性脊柱炎患者,评估髋关节临床、超声和影像学受累情况。基线时20%有髋关节受累史、23%有髋关节压痛、17%有超声炎症病变、10%有影像学结构损伤。治疗6个月后髋关节压痛、超声炎症病变总数和能量多普勒阳性均显著减少。

要点

  • 活动性强直性脊柱炎患者髋关节受累比例因评估方式不同为10%至23%。
  • TNF-α阻断治疗6个月可显著改善髋关节压痛及超声炎症病变。
  • 髋关节受累史与影像学髋关节受累的一致性最高。

核心结论

  • 强直性脊柱炎患者髋关节受累的患病率因评估类型不同为10%至23%。
  • TNF-α阻断治疗显著改善髋关节压痛及包括能量多普勒阳性的超声炎症病变。

研究设计与样本

  • 研究纳入111例开始TNF-α阻断治疗的活动性强直性脊柱炎连续患者。
  • 基线评估髋关节受累史和放射学BASRI-hip,并在治疗前及治疗6个月后行临床压痛髋关节检查和超声检查。

主要发现

  • 111例患者中20%报告髋关节受累史,基线时23%存在压痛髋关节。
  • 超声显示17%患者有炎症病变,其中74%能量多普勒阳性;20%有结构病变,其中55%有骨赘。
  • 放射学结构损伤见于10%患者,髋关节受累史与放射学髋关节受累的一致性最高(phi系数0.333)。
  • TNF-α阻断治疗6个月后,压痛髋关节从29降至11,炎症超声病变总数从29降至9,能量多普勒阳性从22降至6。

关键数值与推荐

  • 髋关节受累史与放射学髋关节受累的phi系数为0.333。
  • 治疗6个月后压痛髋关节由29降至11,炎症超声病变总数由29降至9,能量多普勒阳性由22降至6。

临床怎么用

  • 对活动性强直性脊柱炎患者应关注髋关节受累,可结合病史、临床检查和超声评估。
  • TNF-α阻断治疗6个月可改善髋关节压痛及超声炎症病变,可作为疗效监测指标。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To assess the prevalence of clinical, US and radiographic hip involvement in AS patients with active disease and to explore the associations between these assessments. Furthermore, to evaluate the effect of 6 months of TNF-α blocking therapy on tender and inflammatory power Doppler US lesions of hip joints. METHODS: Consecutive AS patients starting TNF-α blocking therapy were evaluated for hip joint involvement. At baseline, patient-reported history of hip involvement was assessed and radiographic evaluation (BASRI-hip) was performed. Clinical examination (tender hip joints) and US examination took place before and after 6 months of treatment. RESULTS: Of the 111 included patients, 20% reported a history of hip involvement. At baseline, tender hip joints were present in 23% of patients. US examination showed inflammatory lesions in 17% of patients, of which 74% had positive power Doppler. Structural lesions were present in 20% of patients, of which 55% had osteophytes. Structural radiographic damage was seen in 10% of patients. Highest concordance was found between history of hip involvement and radiographic hip involvement (phi coefficient 0.333). After 6 months of TNF-α blocking therapy, significant decrease was found in tender hip joints (from 29 to 11), total number of inflammatory US lesions (from 29 to 9) and positive power Doppler (from 22 to 6). CONCLUSION: The prevalence rate of hip involvement in AS patients varies from 10 to 23%, depending on the type of hip assessment. TNF-α blocking therapy significantly improved tender hip joints, and inflammatory US lesions including positive power Doppler.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Wink F, Arends S, Maas F, et al. High prevalence of hip involvement and decrease in inflammatory ultrasound lesions during tumour necrosis factor-α blocking therapy in ankylosing spondylitis. Rheumatology (Oxford). 2019. PMID: 30624693. doi:10.1093/rheumatology/key382

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。